Do medications we commonly prescribe for secondary prevention of CAD have similar benefits in the perioperative period?
After estimating a patient’s risk of perioperative cardiac events you then have to decide if that risk can and should be reduced with medical or nonmedical interventions. A variety of medications commonly used for secondary prevention of CAD have also been studied for their utility in preventing perioperative cardiovascular events and death.
- Prescribe medications shown to reduce perioperative cardiovascular events (R2, R3)
Review case 5 for this section of the module.
- 2014 ACC Guidelines pgs 42-54.
- Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery (just review the summary pdf and figures)
- Effect of perioperative statins on death, mi, atrial fibrillation, and length of stay (has additional outcomes that the Cochrane review didn’t)
- Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery
- Perioperative beta blockade in noncardiac surgery: A systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery (gives similar results to #4 but was specifically done for the updated guideline)
Videos: (Total viewing time: 17:04)
- Reducing Perioperative Cardiac Risk: Do Statins Help? (5:42)
- Reducing Perioperative Cardiac Risk: Do Beta-blockers Help? (11:22)
Annotated PowerPoint Slides: (Note: To download the slides click “Save” at the top of the presentation. After downloading, click on the “View” tab and view as “Notes Page”)